Trillium Therapeutics Inc (TRIL)

[vinmantoo]

Yeah I've read the Shareholders meeting was very positive. I agree the valuation gap will be the short term driver. If the 621 data is stellar, maybe a buyout coming out of phase 1, but usually following phase 2 is more the norm

The delay is in patient recruiting for TTI-621 due to COVID-19 concerns but TTI-622 is on schedule and performing better than expected and there is no delay in recruiting for it.

AS far as a potential buyout, I don't want one after phase I unless the price is significantly higher than what GILD paid for FTSV.